Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although melatonin is increasingly used for sleep disturbances in children with neurodevelopmental disorders, evidence on effective dose and impact on specific types of sleep disturbance is limited. METHOD: We assessed 45 children (35 males, mean age: 6.3 ± 1.7 years) with neurodevelopmental disorders (n = 29: intellectual disability; n = 9: autism spectrum disorder; n = 7: attention-deficit/hyperactivity disorder) and sleep disturbances, treated with melatonin (mean duration: 326 days) with doses increased according to response. RESULTS: Thirty-eight percent of children responded to low (2.5-3 mg), 31% to medium (5-6 mg) and 9% to high doses (9-10 mg) of melatonin, with a significant increase in total hours of sleep/night, decreased sleep onset delay and decreased number of awakenings/night (all: p = 0.001), as measured with sleep diaries. No serious adverse events were reported. CONCLUSIONS: Melatonin is generally effective and safe in children with neurodevelopmental conditions. Increasing above 6 mg/night adds further benefit only in a small percentage of children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortese, S., Faraone, S. V., Konofal, E., & Lecendreux, M. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181ac09c9 · Cited by 637
Self-citationFishman (2006) · doi:10.1097/01 · Cited by 547
Melatonin in autism spectrum disorders: a systematic review and meta-analysis
ROSSIGNOL, D. A., & FRYE, R. E. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2011.03980.x · Cited by 468 · cited 2×
“Our results are also in line with a more recent meta-analysis of five randomized double-blind placebocontrolled studies in children with ASD, showing a significant improvement in sleep latency and total sleep duration in 80% of the participants [17].”
ResultThe relationship between sleep and behavior in autism spectrum disorder (ASD): a review
Cohen, S., Conduit, R., Lockley, S. W., Rajaratnam, S. M., & Cornish, K. M. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-44 · Cited by 389
Effect of Melatonin on Sleep, Behavior, and Cognition in ADHD and Chronic Sleep-Onset Insomnia
VAN der HEIJDEN, K. B., SMITS, M. G., VAN SOMEREN, E. J. W., RIDDERINKHOF, K. R., & GUNNING, W. B. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246055.76167.0d · Cited by 378 · cited 2×
“, [13,14,16,21]) and available long-term follow-up studies (e.”
MethodLong‐term follow‐up of melatonin treatment in children with ADHD and chronic sleep onset insomnia
Hoebert, M., Van Der Heijden, K. B., Van Geijlswijk, I. M., & Smits, M. G. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00681.x · Cited by 220
Future Research Directions in Sleep and ADHD: Report of a Consensus Working Group
Owens, J., Gruber, R., Brown, T., Corkum, P., Cortese, S., O’Brien, L., Stein, M., & Weiss, M. (2013) · Journal of Attention Disorders · doi:10.1177/1087054712457992 · Cited by 143
Self-citationTjon Pian Gi, C. V., Broeren, J. P. A., Starreveld, J. S., & A. Versteegh, F. G. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1207-x · Cited by 85 · cited 1×
“In relation to ADHD, the working group retrieved a total of five trials of melatonin [12–16], including three randomized controlled trials [13,14,16], all showing positive effects of melatonin on sleep disturbances, with, overall, a safe tolerability profile.”
MethodMcKenna, B. S., & Eyler, L. T. (2012) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.07.003 · Cited by 69 · cited 1×
“Children with neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD) [1–5], autism spectrum disorder (ASD) [6,7] and intellectual disability (ID) [8], may present with sleep disturbances that further impact on their cognitive and emotional development [9], aggravating the functional im…”
Background
Cited by
Carmassi, C., Palagini, L., Caruso, D., Masci, I., Nobili, L., Vita, A., & Dell’Osso, L. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00366 · Cited by 220
Masi, G., Fantozzi, P., Villafranca, A., Tacchi, A., Ricci, F., Ruglioni, L., Inguaggiato, E., Pfanner, C., & Cortese, S. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s193891 · Cited by 34
“5–6 mg/d), whereas doses above 6 mg added further benefit only in a small percentage of children.(23) A strength of this study is that it is based on a consecutive, unselected sample of children naturalistically treated, with few exclusion criteria (except for intellectual disability, autism spectrum disorders and sch…”
BackgroundSelf-citationA Practice Pathway for the Treatment of Night Wakings in Children with Autism Spectrum Disorder
Galion, A. W., Farmer, J. G., Connolly, H. V., Allhusen, V. D., Bennett, A., Coury, D. L., Lam, J., Neumeyer, A. M., Sohl, K., Witmans, M., et al. (2024) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06026-2 · Cited by 15
Sleep Medicine - Asleep or Awake?
(2024) · doi:10.5772/intechopen.104201 · Cited by 5
Metadata
- Authors
- Ayyash, H. F., Preece, P., Morton, R., & Cortese, S.
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2015-05-04
- Volume
- 15
- Issue
- 6
- Pages
- 711-717
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W2172086945
- Cited by
- 30
- References
- 9
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study. https://app.cochat.ai/papers/10.1586/14737175.2015.1041511
- The paper
- Ayyash, H. F., Preece, P., Morton, R., & Cortese, S. (2015). Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.2015.1041511
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.